Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.49 +0.01 (+0.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Price to Earnings (2013 - 2026)

Updated

Oramed Pharmaceuticals' (ORMP) Price to Earnings was 1.14 for Q2 2026, down 10.2% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Price to Earnings (2013 - 2026) Analysis & Trends

For FY2025, Price to Earnings at Oramed Pharmaceuticals was 1.75.

  • By year, Price to Earnings came in at 18.31 in FY2023 and 33.17 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Price to Earnings in data going back to Q4 2013.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 1.26 (Q1 2026), 1.75 (Q4 2025) and 2.46 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Oramed Pharmaceuticals 185.50 Mn 185.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14
Mar 31, 2026 1.26
Dec 31, 2025 1.75
Sep 30, 2025 2.46
Sep 30, 2024 24.36
Jun 30, 2024 5.11
Mar 31, 2024 11.81
Dec 31, 2023 18.31
May 31, 2014 11.42
Feb 28, 2014 34.78
Nov 30, 2013 16.22
Aug 31, 2013 13.67
API Access

Oramed Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ORMP&period=max&api_key=YOUR_API_KEY